Nexilis AG commercialises research-innovations through selection and development of feasible applications, securing technology proofs and defining/clarifying industrial value, in order to develop products in the overlapping field between MedTech and BioTech based on licenced and own IP rights. Nexilis AG supports its partners:
• to secure IP-rights to create value in the early stages of the project
• to develop and focus the project to obtain early technology proofs
• to focus on market understanding early
• to find the right partners early.
• in strategic planning,
• in business development
• in product management,
Strategic Planning
Nexilis AG supports companies in the strategic planning in the following areas:
• Market Analysis
• Analysis of Competitors
• Positioning
• Technology Management
• Intellectual Property Management Strategies
• Regulatory Strategies
• Interim Management
• Evaluating new Licensing Opportunities
• Risk Management
Business Development
Nexilis AG has long standing experiences in business development activities. Nexilis partners could profit from the following services:
• Portfolio analysis of products
• Portfolio Analysis of Development Projects
• Finding and evaluating partners
• Evaluation of Licensing Opportunities
• Identifying Investors
• Due Diligence
Product Development
Development of new products is one of the core competences of each pharmaceutical, medical device and Biotechnology Company. That begins with the first idea, leads to the preclinical research and finally to production processes under special considerations of quality and regulatory aspects. Nexilis AG offers its partners support in the following areas:
• Defining clinical Needs
• Planning of preclinical Studies
• Planning of clinical Studies
• Managing the clinical Interface and clinical Studies
• Purchasing of medical Grade raw Materials
• Evaluation of Suppliers |
